Clinical trials
Active, not recruiting Esophageal Squamous Cell Carcinoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 4 |
| 2024 | 6 |
| 2025 | 3 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 4 |
| Sun Yat-sen University | 4 |
| Fudan University | 3 |
| Peking University | 2 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 2 |
| AstraZeneca | 1 |
| Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 1 |
| First Affiliated Hospital of Zhejiang University | 1 |
| Harbin Medical University | 1 |
| Li Zhang | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Esophageal Squamous Cell Carcinoma | 29 |
| Esophageal Neoplasms | 3 |
| Biliary Tract Neoplasms | 1 |
| Colorectal Neoplasms | 1 |
| Gastrointestinal Neoplasms | 1 |
| Gastrointestinal Stromal Tumors | 1 |
| Neoplasms, Unknown Primary | 1 |
| Neuroendocrine Tumors | 1 |
| Pancreatic Neoplasms | 1 |
| Postoperative Complications | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.